Abstract

Objective: Cholestasis in childhood results from different etiologies according to age groups. The differences between clinical and laboratory findings in patients with cholestasis during the first 3 months of age and after 3 months are unknown. The aim of this study is to investigate the clinical, laboratory; and histopathological findings of patients with cholestasis according to age groups.

Material and Methods: Between January 2013-March 2017, files of the patients diagnosed as cholestasis in 0-18 year of age were retrospectively reviewed. Demographic data, complaints, physical examination, laboratory, ultrasonography and if liver biopsy is done histopathologic findings of the patients were recorded.

Results: Forty-four patients (29 M, 65%) were diagnosed as cholestasis during the study period. Twenty-five (56%) of the patients were younger than 3 months (Group 1), 19 (44%) of the patients were older than 3 months (Group 2). The patients were diagnosed as cholestasis in the first 3 months were idiopathic neonatal hepatitis (n=5, 20%), non-syndromic paucity of intrahepatic bile ducts (n=5, 20%), biliary atresia (n=3, 12%), progressive familial intrahepatic cholestasis (n=3, 12%), cholestasis owing to prematurity/ sepsis/ parenteral nutrition (n=3, 12%) respectively. Aetiology of the cholestasis after 3 months were cryptogenic hepatitis (n=5, 26.3%) and autoimmune hepatitis (n=4, 21%) respectively. Mean duration of follow up was 17.7±15.1 months. Total and direct bilirubin levels were higher in Group 1 patients (p=0.017 and p= 0.023 respectively) whereas albumin levels were lower (p=0.051). Ultrasonographic evaluation revealed statistically homogenic liver parenchyma in Group 1 (p=0.000). Liver histopathologic examination showed fibrosis in Group 2 (p=0.000).

Conclusion: Cholestasis in childhood occurs different reasons. Although bilirubin levels were higher in young children, chronic changes such as liver fibrosis are common in older children.

Keywords: Child, Infant, Cholestasis, Liver diseases

References

  1. Venigalla S, Gourley GR. Neonatal cholestasis. Seminars in perinatology. 2004; 28: 348-55.
  2. Squires JE, McKiernan P. Molecular Mechanisms in Pediatric Cholestasis. Gastroenterol Clin North Am 2018;47:921-37.
  3. Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of pediatric gastroenterology and nutrition. 2017; 64: 154-68.
  4. Lane E, Murray KF. Neonatal Cholestasis. Pediatric clinics of North America. 2017; 64: 621-39.
  5. Pereira TN, Walsh MJ, Lewindon PJ, Ramm GA. Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World journal of gastrointestinal pathophysiology. 2010; 1: 69-84.
  6. Takcı Ş, Günbey C, Yurdakök M, Korkmaz A, Yiğit Ş. Çok düşük doğum ağırlıklı bebeklerde neonatal kolestaz. Çocuk Sağlığı ve Hastalıkları Dergisi. 2013; 56: 175-80.
  7. Sokol RJ, Mack C, Narkewicz MR, Karrer FM. Pathogenesis and outcome of biliary atresia: current concepts. Journal of pediatric gastroenterology and nutrition. 2003; 37: 4-21.
  8. Gökçebay DG, Gülerman HF, Arda N, Atavci S. Evaluation of Infants with Neonatal Cholestasis: Experience of a Tertiary Referral Center in Turkey/Neonatal Kolestazli Infantlarin Degerlendirilmesi: Türkiye’den Bir Üçüncü Basamak Referans Merkezinin Deneyimi. Türkiye Klinikleri Tip Bilimleri Dergisi 2015;35:218.
  9. Mieli-Vergani G, Howard ER, Mowat AP. Liver disease in infancy: a 20 year perspective. Gut 1991;Suppl:S123-8.
  10. Çayır H, Altuntaş B, Ertan Ü. Neonatal kolestaz olgularında ekstrahepatik bilier hastalık ve hepatoselüler hastalıkların ayırıcı tanısı: 37 olgunun prospektif analizi. Turkiye Klinikleri Journal of Pediatrics. 1998; 7: 175-81.
  11. Doğancı T, Acun C, Yaşar Z, Mısırlıoğlu E. Neonatal kolestazlı vakaların geç dönemde değerlendirmesi. Çocuk Sağlığı ve Hastalıkları Dergisi. 2002; 45: 216-21.
  12. Kuloğlu Z, Ödek Ç, Kırsaçlıoğlu CT, Kansu A, Erden E, Girgin N, ve ark. Yenidoğan kolestazı olan 50 vakanın değerlendirilmesi. Çocuk Sağlığı ve Hastalıkları Dergisi. 2008; 51: 140-6.
  13. Urgancı N, Çetinkaya F, Kalyoncu D, Papatya Çakır E, Yılmaz B. Infants with Cholestasis: Diagnosis, Management and Outcome. Marmara Medical Journal 2012;25.
  14. Tosun Yıldırım H, Diniz G, Aktaş S, Ortaç R, Ergin M, Targan Ş, et al. Neonatal kolestazda histopatolojik ayırıcı tanı. İzmir Dr Behçet Uz Çocuk Hast Dergisi 3:28-32.
  15. Demirhan A, Önal Z, Gülcan M. Neonatal Kolestaz Tanısıyla İzlenen Olguların Değerlendirilmesi. Çocuk Dergisi 18:59-68.
  16. Sökücü S, Saner G, Dindar A, Güleçyüz M. Süt Çocukluğu Dönemi Kolestazlı Hastalarımızda Etyolojik Dağılım. T Klin Gastroenterohepatoloji 1991;2:130-4.
  17. Bıçakcıoğlu I, Özdemir R, Turgut H, Gökçe İK, Selimoğlu MA. Neonatal kolestaz: 94 olgunun geriye dönük incelenmesi. Çocuk Sağlığı ve Hastalıkları Dergisi 2017;60-129-38.
  18. Demir H, Hizal G, Uslu-Kizilkan N, Gürakan F, Talim B, Coskun T, et al. Serum alpha-fetoprotein levels in neonatal cholestasis. Turk j pediatr 2013;55:152-7.
  19. Takagi K, Tanaka H, Nishijima S, Masaoka N, Miyake Y, Sakata H, et al. Fetal blood values by percutaneous umbilical blood sampling. Fetal ther 1989;4:152-60.
  20. Kaysen GA. Biochemistry and biomarkers of inflamed patients: why look, what to assess. Clin J Am Soc Nephrol 2009;4 Suppl 1:S56-63.
  21. Rockey DC, Friedman SL. Hepatic Fibrosis and Cirrhosis. In: Zakim and Boyer’s Hepatology: A Textbook of Liver Disease. 6th ed. Philadelphia. Elsevier Inc 2012;64-85.
  22. Suchy FJ. Approach to the infant with cholestasis. In: Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver Disease in Children. 3rd Ed. New York: Cambridge University Press 2007; 179-89.

Copyright and license

Copyright © 2020 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Demir AM, Yaman A, Hızal G, Berberoğlu Ateş B, Tuna Kırsaçlıoğlu C, Ece D, et al. Evaluation of Clinical and Laboratory Findings in Childhood Cholestasis According To Age Groups. Turk J Pediatr Dis [Internet]. 2020 Sep. 29 [cited 2025 Aug. 23];14(5):385-90. Available from: https://turkjpediatrdis.org/article/view/657